SEARCH

SEARCH BY CITATION

5 References

  • 1
    Symonds, M. E., Sebert, S., Budge, H., The obesity epidemic: from the environment to epigenetics - not simply a response to dietary manipulation in a thermoneutral environment. Front. Genet. 2011, 2, 24.
  • 2
    Madsen, L., Pedersen, L. M., Liaset, B., Ma, T. et al., cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J. Biol. Chem. 2008, 283, 71967205.
  • 3
    Ailhaud, G., Guesnet, P., Cunnane, S. C., An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?. Brit. J. Nutr. 2008, 100, 461470.
  • 4
    Ailhaud, G., Massiera, F., Weill, P., Legrand, P. et al., Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog. Lipid Res. 2006, 45, 203236.
  • 5
    Massiera, F., Saint-Marc, P., Seydoux, J., Murata, T. et al., Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?. J. Lipid Res. 2003, 44, 271279.
  • 6
    Flachs, P., Rossmeisl, M., Bryhn, M., Kopecky, J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin. Sci. (Lond.) 2009, 116, 116.
  • 7
    Simoncikova, P., Wein, S., Gasperikova, D., Ukropec, J. et al., Comparison of the extrapancreatic action of gamma-linolenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance. Endocr. Regul. 2002, 36, 143149.
  • 8
    Storlien, L. H., Jenkins, A. B., Chisholm, D. J., Pascoe, W. S. et al., Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40, 280289.
  • 9
    Halvorsen, B., Rustan, A. C., Madsen, L., Reseland, J. et al., Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats. Ann. Nutr. Metab. 2001, 45, 3037.
  • 10
    Fernandez-Twinn, D. S., Ozanne, S. E., Early life nutrition and metabolic programming. Ann. N. Y. Acad. Sci. 2010, 1212, 7896.
  • 11
    Symonds, M. E., Gardner, D. S. Experimental evidence for early nutritional programming of later health in animals. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 278283.
  • 12
    Weisinger, H. S., Armitage, J. A., Sinclair, A. J., Vingrys, A. J. et al., Perinatal omega-3 fatty acid deficiency affects blood pressure later in life. Nat. Med. 2001, 7, 258259.
  • 13
    Helland, I. B., Smith, L., Saarem, K., Saugstad, O. D. et al., Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111, e39-e44.
  • 14
    Donahue, S. M., Rifas-Shiman, S. L., Gold, D. R., Jouni, Z. E. et al., Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort. Am. J. Clin. Nutr. 2011, 93, 780788.
  • 15
    Zadelaar, S., Kleemann, R., Verschuren, L., de Vries-Van der Weij, J. et al., Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 17061721.
  • 16
    Kleemann, R., van Erk, M., Verschuren, L., van den Hoek, A. M. et al., Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One. 2010, 5, e8817.
  • 17
    Wielinga, P. Y., Yakala, G. K., Heeringa, P., Kleemann, R. et al., Beneficial effects of alternate dietary regimen on liver inflammation, atherosclerosis and renal activation. PLoS One. 2011, 6, e18432.
  • 18
    Verschuren, L., Kleemann, R., Offerman, E. H., Szalai, A. J. et al., Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 161167.
  • 19
    Verschuren, L., Kooistra, T., Bernhagen, J., Voshol, P. J. et al., MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ. Res. 2009, 105, 99107.
  • 20
    Cinti, S., Mitchell, G., Barbatelli, G., Murano, I. et al., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46, 23472355.
  • 21
    Miralles, O., Sanchez, J., Palou, A., Pico, C., A physiological role of breast milk leptin in body weight control in developing infants. Obesity. (Silver. Spring). 2006, 14, 13711377.
  • 22
    Korotkova, M., Gabrielsson, B. G., Holmang, A., Larsson, B. M. et al., Gender-related long-term effects in adult rats by perinatal dietary ratio of n-6/n-3 fatty acids. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R575R579.
  • 23
    Kasbi, C. F., Andre, A., Prieur, X., Loirand, G. et al., n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet. Brit. J. Nutr. 2012, 107, 13051315.
  • 24
    Sato, A., Kawano, H., Notsu, T., Ohta, M. et al., Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010, 59, 24952504.
  • 25
    Oosting, A., Kegler, D., Boehm, G., Jansen, H. T. et al., N-3 long-chain polyunsaturated fatty acids prevent excessive fat deposition in adulthood in a mouse model of postnatal nutritional programming. Pediatr. Res. 2010, 68, 494499.
  • 26
    Ruzickova, J., Rossmeisl, M., Prazak, T., Flachs, P. et al., Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004, 39, 11771185.
  • 27
    Skurnick-Minot, G., Laromiguiere, M., Oppert, J., Quignard-Boulange, A. M. et. al., Whole-body fat mass and insulin sensitivity in type 2 diabetes women: effect of n-3 polyunsaturated fatty acids. Diabetes 2004, 53, A44.
  • 28
    Kim, H. K., la-Fera, M., Lin, J., Baile, C. A., Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J. Nutr. 2006, 136, 29652969.
  • 29
    Oliver, E., McGillicuddy, F., Phillips, C., Toomey, S. et al., The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Proc. Nutr. Soc. 2010, 69, 232243.
  • 30
    Todoric, J., Loffler, M., Huber, J., Bilban, M. et al., Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia. 2006, 49, 21092119.
  • 31
    Titos, E., Rius, B., Gonzalez-Periz, A., Lopez-Vicario, C. et al., Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol. 2011, 187, 54085418.
  • 32
    Blum, C. B., Levy, R. I., Role of dietary intervention in the primary prevention of coronary heart disease. Individuals with high-normal or elevated serum cholesterol levels should be placed on cholesterol-lowering diets. Cardiology 1987, 74, 221.
  • 33
    Cottin, S. C., Sanders, T. A., Hall, W. L., The differential effects of EPA and DHA on cardiovascular risk factors. Proc. Nutr. Soc. 2011, 70, 215231.
  • 34
    Korotkova, M., Gabrielsson, B. G., Holmang, A., Larsson, B. M. et al., Gender-related long-term effects in adult rats by perinatal dietary ratio of n-6/n-3 fatty acids. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R575R579.
  • 35
    Korotkova, M., Gabrielsson, B., Lonn, M., Hanson, L. A. et al., Leptin levels in rat offspring are modified by the ratio of linoleic to alpha-linolenic acid in the maternal diet. J. Lipid Res. 2002, 43, 17431749.
  • 36
    Lefils, J., Geloen, A., Vidal, H., Lagarde, M. et al., Dietary DHA: time course of tissue uptake and effects on cytokine secretion in mice. Brit. J. Nutr. 2010, 104, 13041312.
  • 37
    Gregor, M. F., Hotamisligil, G. S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415445.
  • 38
    Gonzalez-Periz, A., Horrillo, R., Ferre, N., Gronert, K. et al., Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009, 23, 19461957.
  • 39
    Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T. et al., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142, 687698.
  • 40
    Das, U. N., Is obesity an inflammatory condition? Nutrition 2001, 17, 953966.
  • 41
    Golub, N., Geba, D., Mousa, S. A., Williams, G. et al., Greasing the wheels of managing overweight and obesity with omega-3 fatty acids. Med. Hypotheses 2011, 77, 11141120.
  • 42
    Yehuda, S., Carasso, R. L., Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified alpha-linolenic and linoleic acids: determination of the optimal omega 3-to-omega 6 ratio. Proc. Natl. Acad. Sci. USA 1993, 90, 1034510349.